Spots Global Cancer Trial Database for recurrent anaplastic astrocytoma
Every month we try and update this database with for recurrent anaplastic astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma | NCT00003470 | Anaplastic Astr... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas | NCT05737212 | Recurrent High-... Recurrent Gliob... Recurrent Anapl... Recurrent Anapl... | 500mg/kg/3hr fo... 500mg/kg/3hr fo... 500mg/kg/3hr fo... | 19 Years - 80 Years | Dawonmedax Co., Ltd. | |
| Low Dose Radiation Therapy for Glioblastoma Multiforme | NCT01466686 | High Grade Glio... | Low Dose Fracti... Temozolomide | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma | NCT00003470 | Anaplastic Astr... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas | NCT02192359 | Recurrent Anapl... Recurrent Anapl... Recurrent Anapl... Recurrent Gliob... Recurrent Glios... Recurrent Malig... Recurrent WHO G... | Carboxylesteras... Irinotecan Irinotecan Hydr... Laboratory Biom... Pharmacological... | 18 Years - 69 Years | City of Hope Medical Center | |
| Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients | NCT02796261 | Anaplastic Astr... Recurrent Anapl... | Eflornithine Lomustine Lomustine | 18 Years - | Orbus Therapeutics, Inc. | |
| Low Dose Radiation Therapy for Glioblastoma Multiforme | NCT01466686 | High Grade Glio... | Low Dose Fracti... Temozolomide | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma | NCT03022578 | IDH Family Wild... Recurrent Anapl... Recurrent Gliob... | Laser Interstit... Lomustine | 18 Years - | M.D. Anderson Cancer Center | |
| Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients | NCT02796261 | Anaplastic Astr... Recurrent Anapl... | Eflornithine Lomustine Lomustine | 18 Years - | Orbus Therapeutics, Inc. | |
| Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas | NCT05139056 | Recurrent Anapl... Recurrent Anapl... Recurrent Anapl... Recurrent Gliob... Recurrent Glios... Recurrent Malig... Recurrent WHO G... Recurrent WHO G... | Neural Stem Cel... Resection | 18 Years - | City of Hope Medical Center | |
| Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas | NCT00360828 | Astrocytoma Glioma Oligodendroglio... | Irinotecan Hydr... Continued Irino... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
